Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The PML (promyelocytic leukemia) protein, also called TRIM19, is an interferon-induced antiviral factor. It directs the formation of nuclear bodies that are rich in heavily SUMOylated proteins and are often associated with viral replication sites. PML can “silence” (prevent the expression of) several viruses, including retroviruses, and its action is often counteracted by viral proteins.
We have recently set up a murine model to study the role of PML in the restriction (inhibition) of retroviral replication. By examining specific steps of the replication of HIV-1 and other retroviruses in cells isolated from wild-type or from PML-knockout mice, we can identify and characterize the effect of PML on pre- and post-integration steps.
An manuscript is in preparation, and I expect that this project will expand. By 2015, we will be conducint mechanistic studies, including:
– Microscopic analyses of PML-viral DNA co-localization
– Biochemical analyses of the physical interactions between PML, or cellular proteins found at PML bodies, with retroviral proteins and genomic DNA.
– Development of in vivo models to test the importance of PML in restricting a retrovirus.
Lionel Berthoux
PEARL CHERRY
Biology
Globalink
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.